title: [Transurethral vaporization of the prostate for benign hypertrophy: preliminary clinical and histological study].
abstract: Twenty five patients with symptomatic BPH and normal PSA underwent electrovaporization. The mean IPSS was 21.5 before and 7.8 three months after treatment while the mean peakflow was 7.1 ml/s and became 16.9. With a short hospital stay (3 days) and a very low morbidity, electrovaporization seems to be a good alternative to TURP. A longer follow-up is necessary.
authors.affiliation: Clinique Urologique (Pr B. Debré), Hôpital Cochin, Paris.
authors.forename: M
authors.initials: M
authors.lastname: Zerbib
authors.forename: S
authors.initials: S
authors.lastname: Conquy
authors.forename: E
authors.initials: E
authors.lastname: Younes
authors.forename: N
authors.initials: N
authors.lastname: Thiounn
authors.forename: T A
authors.initials: TA
authors.lastname: Flam
authors.forename: B
authors.initials: B
authors.lastname: Debré
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004564:Electrocoagulation / Q000009:adverse effects; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000473:pathology / Q000601:surgery*; D011788:Quality of Life